☰

Pam M. Van Ry, Ph.D. - Publications

Affiliations: 
2014 Cell and Molecular Pharmacology and Physiology University of Nevada, Reno, Reno, NV, United States 
Area:
Molecular Biology, Pharmacology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Vallecillo-Zúniga ML, Rathgeber M, Poulson D, Kartchner B, Luddington J, Gill H, Hayes S, Teynor M, Stowell CS, Arthur CM, Stowell SR, Van Ry PM. Evaluating Therapeutic Activity of Galectin-1 in Sarcolemma Repair of Skeletal Muscle. Methods in Molecular Biology (Clifton, N.J.). 2442: 663-683. PMID 35320552 DOI: 10.1007/978-1-0716-2055-7_36  0.515
2021 Vallecillo-Zúniga ML, Poulson PD, Luddington JS, Arnold CJ, Rathgeber M, Kartchner BC, Hayes S, Gill H, Valdoz JC, Spallino JL, Garfield S, Dodson EL, Arthur CM, Stowell SR, Van Ry PM. Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B. Cells. 10. PMID 34831431 DOI: 10.3390/cells10113210  0.506
2020 Vallecillo-Zúniga ML, Rathgeber MF, Poulson PD, Hayes S, Luddington JS, Gill HN, Teynor M, Kartchner BC, Valdoz J, Stowell C, Markham AR, Arthur C, Stowell S, Van Ry PM. Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models. Plos One. 15: e0238441. PMID 32881965 DOI: 10.1371/Journal.Pone.0238441  0.309
2019 Wuebbles RD, Cruz V, Van Ry P, Barraza-Flores P, Brewer PD, Jones P, Burkin DJ. Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy. Molecular Therapy. Methods & Clinical Development. 13: 145-153. PMID 30788383 DOI: 10.1016/J.Omtm.2019.01.004  0.677
2017 Van Ry PM, Fontelonga TM, Barraza-Flores P, Sarathy A, Nunes AM, Burkin DJ. ECM-Related Myopathies and Muscular Dystrophies: Pros and Cons of Protein Therapies. Comprehensive Physiology. 7: 1519-1536. PMID 28915335 DOI: 10.1002/Cphy.C150033  0.741
2017 Willmann R, Gordish-Dressman H, Meinen S, Rüegg MA, Yu Q, Nagaraju K, Kumar A, Girgenrath M, Coffey CBM, Cruz V, Van Ry PM, Bogdanik L, Lutz C, Rutkowski A, Burkin DJ. Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy. Journal of Neuromuscular Diseases. PMID 28550268 DOI: 10.3233/Jnd-170217  0.692
2017 Lewon M, Peters CM, Van Ry PM, Burkin DJ, Hunter KW, Hayes LJ. Evaluation of the behavioral characteristics of the mdx mouse model of duchenne muscular dystrophy through operant conditioning procedures. Behavioural Processes. 142: 8-20. PMID 28532665 DOI: 10.1016/J.Beproc.2017.05.012  0.59
2017 Doe J, Kaindl AM, Jijiwa M, de la Vega M, Hu H, Griffiths GS, Fontelonga TM, Barraza P, Cruz V, Van Ry P, Ramos JW, Burkin DJ, Matter ML. PTRH2 gene mutation causes progressive congenital skeletal muscle pathology. Human Molecular Genetics. PMID 28175314 DOI: 10.1093/Hmg/Ddx048  0.619
2015 Van Ry PM, Wuebbles RD, Key M, Burkin DJ. Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 1285-97. PMID 26050991 DOI: 10.1038/Mt.2015.105  0.792
2015 Griffiths GS, Doe J, Jijiwa M, Van Ry P, Cruz V, de la Vega M, Ramos JW, Burkin DJ, Matter ML. Bit-1 is an essential regulator of myogenic differentiation. Journal of Cell Science. 128: 1707-17. PMID 25770104 DOI: 10.1242/Dev.125765  0.596
2014 Van Ry PM, Minogue P, Hodges BL, Burkin DJ. Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy. Human Molecular Genetics. 23: 383-96. PMID 24009313 DOI: 10.1093/Hmg/Ddt428  0.793
Show low-probability matches.